Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
1.07
-0.01 (-1.38%)
At close: May 15, 2025, 2:08 PM
Virax Biolabs Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for VRAX stock have an median target of 3, with a low estimate of 3 and a high estimate of 3. The median target predicts an increase of 180.37% from the current stock price of 1.07.
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Virax Biolabs Group Limited is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
Financial Forecast this Year
Revenue This Year
8M
from 156.42K
Increased by 5.01K%
Revenue Next Year
13.49M
from 8M
Increased by 68.7%
EPS This Year
-0.6
from -3.36
Increased by 82.1%
EPS Next Year
0.4
from -0.6
Increased by 33.3%